| Ident. | Authors (with country if any) | Title |
|---|
| 000002 (2020) |
Ritesh Gupta [Inde] ; Anoop Misra [Inde] | Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). |
| 000003 (2020) |
Manish Bansal [Inde] | Cardiovascular disease and COVID-19. |
| 000004 (2020) |
S. Harikrishnan [Inde] ; P P Mohanan [Inde] ; V K Chopra [Inde] ; Roy Ambuj [Inde] ; G. Sanjay [Inde] ; Manish Bansal [Inde] ; R N Chakraborty [Inde] ; Sharad Chandra [Inde] ; S S Chattarjee [Inde] ; H K Chopra ; Cibu Mathew [Inde] ; P K Deb [Inde] ; A. Goyal [Inde] ; K C Goswami [Inde] ; R. Gupta [Inde] ; S. Guha [Inde] ; V. Gupta [Inde] ; P K Hasija [Inde] ; Harsh Wardhan [Inde] ; A. Jabir [Inde] ; P B Jayagopal [Inde] ; D. Kahali [Inde] ; V K Katyal [Inde] ; P G Kerkar [Inde] ; N N Khanna [Inde] ; B. Majumder [Inde] ; M. Mandal [Inde] ; C B Meena [Inde] ; N. Naik [Inde] ; V K Narain [Inde] ; L A Pathak [Inde] ; S. Ray [Inde] ; D. Roy [Inde] ; S N Routray [Inde] ; D. Sarma [Inde] ; S. Shanmugasundaram [Inde] ; B P Singh [Inde] ; S K Tyagi [Inde] ; K. Venugopal [Inde] ; G S Wander [Inde] ; Rakesh Yadav [Inde] ; M K Das [Inde] | Cardiological society of India position statement on COVID-19 and heart failure. |
| 000007 (2020) |
Awadhesh Kumar Singh [Inde] ; Ritesh Gupta [Inde] ; Anoop Misra [Inde] | Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. |
| 000058 (2020) |
Meghana Chalasani [États-Unis] ; Khurram Nasir [États-Unis] ; Mohit D. Gupta [Inde] ; Ankur Kalra [États-Unis] | The Covid-19 pandemic and India's cardiovascular disease burden: Finding the right balance. |
| 000072 (2020) |
Baskaran Chandrasekaran [Inde] ; Thiru Balaji Ganesan [Inde] | Sedentarism and chronic disease risk in COVID 19 lockdown - a scoping review. |
| 000078 (2020) |
Rajkumar Singh Kalra [Japon] ; Dhanendra Tomar [États-Unis] ; Avtar Singh Meena [Inde] ; Ramesh Kandimalla [Inde] | SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings. |
| 000080 (2020) |
Jayalakshmi Vallamkondu [Inde] ; Albin John [États-Unis] ; Willayat Yousuf Wani [États-Unis] ; Suguru Pathinti Ramadevi [Inde] ; Kishore Kumar Jella [États-Unis] ; P Hemachandra Reddy [États-Unis] ; Ramesh Kandimalla [Inde] | SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets. |
| 000102 (2020) |
Shiek S S J. Ahmed [Inde] ; Prabu Paramasivam [États-Unis, Inde] ; Kamal Raj [Inde] ; Vishal Kumar [Inde] ; Ram Murugesan [Inde] ; V. Ramakrishnan [Inde] | Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host. |
| 000111 (2020) |
Ray Subir [Inde] ; Mukherjee Jagat J [Inde] ; Gangopadhyay Kalyan K [Inde] | Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19). |
| 000115 (2020) |
Surendra Patel [Inde] ; Atul Kaushik [Inde] ; Alok Kumar Sharma [Inde] | Prioritizing cardiovascular surgical care in COVID-19 pandemic: Shall we operate or defer? |
| 000120 (2020) |
Awadhesh K. Singh [Inde] ; Clare L. Gillies [Royaume-Uni] ; Ritu Singh [Inde] ; Akriti Singh [Inde] ; Yogini Chudasama [Royaume-Uni] ; Briana Coles [Royaume-Uni] ; Sam Seidu [Royaume-Uni] ; Francesco Zaccardi [Royaume-Uni] ; Melanie J. Davies [Royaume-Uni] ; Kamlesh Khunti [Royaume-Uni] | Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. |
| 000161 (2020) |
Praveen Sharma [Inde] ; Ashish Kumar [Inde] | Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19. |
| 000176 (2020) |
Sonu Bhaskar [Australie] ; Aarushi Rastogi [Australie] ; Vijay Kumar Chattu [Australie, Canada] ; Anil Adisesh [Australie, Canada] ; Pravin Thomas [Australie, Royaume-Uni] ; Negman Alvarado [Australie, Argentine] ; Anis D. Riahi [Australie, Tunisie] ; Chakrakodi N. Varun [Australie, Inde] ; Anupama R. Pai [Australie, Inde] ; Sarah Barsam [Australie, Royaume-Uni] ; Antony H. Walker [Australie, Royaume-Uni] | Key Strategies for Clinical Management and Improvement of Healthcare Services for Cardiovascular Disease and Diabetes Patients in the Coronavirus (COVID-19) Settings: Recommendations From the REPROGRAM Consortium. |
| 000192 (2020) |
Bada Sharanappa Nagaraja [Inde] ; Kalhalli Narayanaswamy Ramesh [Inde] ; Debjyoti Dhar [Inde] ; Mahammad Samim Mondal [Inde] ; Treshita Dey [Inde] ; Subhrakamal Saha [Inde] ; Mumtaz Ali Khan [Inde] ; Shah Dhiren Rutul [Inde] ; Kishore Pratik [Inde] ; Jayaram Manjula [Inde] ; Thuppanattumadam Ananthasubramanian Sangeeth [Inde] ; Vikram Singh [Inde] | HyPE study: hydroxychloroquine prophylaxis-related adverse events' analysis among healthcare workers during COVID-19 pandemic: a rising public health concern. |
| 000202 (2020) |
Himanshu Sankrityayan [Inde] ; Ajinath Kale [Inde] ; Nisha Sharma [Inde] ; Hans-Joachim Anders [Allemagne] ; Anil Bhanudas Gaikwad [Inde] | Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder. |
| 000217 (2020) |
Shahir Asfahan [Oman] ; Aneesa Shahul [Oman] ; Gopal Chawla [Oman] ; Naveen Dutt [Inde] ; Ram Niwas [Oman] ; Neeraj Gupta [Oman] | Early trends of socio-economic and health indicators influencing case fatality rate of COVID-19 pandemic. |
| 000267 (2020) |
George M. Varghese [Inde] ; Rebecca John [Inde] ; Abi Manesh [Inde] ; Rajiv Karthik [Inde] ; O C Abraham [Inde] | Clinical management of COVID-19. |
| 000299 (2020) |
Sara Momtazmanesh [Iran] ; Parnian Shobeiri [Iran] ; Sara Hanaei [Iran] ; Hani Mahmoud-Elsayed [Royaume-Uni] ; Bharat Dalvi [Inde] ; Elaheh Malakan Rad [Iran] | Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool. |
| 000301 (2020) |
Seshadri Reddy Varikasuvu [Inde] ; Naveen Dutt [Inde] | Cardiovascular disease as a risk factor of disease progression in COVID-19: The corrected effect size and forest plot. |
| 000321 (2020) |
Kunal Mahajan [Inde] ; Prakash Chand Negi [Inde] ; Neeraj Ganju [Inde] ; Sanjeev Asotra [Inde] | Cardiac biomarker-based risk stratification algorithm in patients with severe COVID-19. |
